Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes.

Giudicessi JR, Ackerman MJ.

Transl Res. 2013 Jan;161(1):1-14. doi: 10.1016/j.trsl.2012.08.005. Review.

2.

Role of pharmacotherapy in cardiac ion channelopathies.

El-Sherif N, Boutjdir M.

Pharmacol Ther. 2015 Nov;155:132-42. doi: 10.1016/j.pharmthera.2015.09.002. Review.

PMID:
26376080
3.
4.

Role of pharmacotherapy in cardiac ion channelopathies.

El-Sherif N, Pedalino R, Himel H 4th.

Curr Vasc Pharmacol. 2009 Jul;7(3):358-66. Review.

PMID:
19601860
5.

Arrhythmogenic hereditary syndromes: Brugada Syndrome, long QT syndrome, short QT syndrome and CPVT.

Schimpf R, Veltmann C, Wolpert C, Borggrefe M.

Minerva Cardioangiol. 2010 Dec;58(6):623-36. Review.

PMID:
21135804
6.

Cardiac channelopathies: genetic and molecular mechanisms.

Abriel H, Zaklyazminskaya EV.

Gene. 2013 Mar 15;517(1):1-11. doi: 10.1016/j.gene.2012.12.061. Review.

PMID:
23266818
7.

Genetic arrhythmias.

Priori SG, Cerrone M.

Ital Heart J. 2005 Mar;6(3):241-8. Review.

PMID:
15875515
8.

Single nucleotide polymorphisms in arrhythmia genes modify the risk of cardiac events and sudden death in long QT syndrome.

Earle N, Yeo Han D, Pilbrow A, Crawford J, Smith W, Shelling AN, Cameron V, Love DR, Skinner JR.

Heart Rhythm. 2014 Jan;11(1):76-82. doi: 10.1016/j.hrthm.2013.10.005.

PMID:
24096169
9.

Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT.

Schimpf R, Veltmann C, Wolpert C, Borggrefe M.

Herz. 2009 Jun;34(4):281-8. doi: 10.1007/s00059-009-3238-1. Review.

PMID:
19575158
10.

Exercise restrictions for patients with inherited cardiac conditions: Current guidelines, challenges and limitations.

Hammond-Haley M, Patel RS, ProvidĂȘncia R, Lambiase PD.

Int J Cardiol. 2016 Apr 15;209:234-41. doi: 10.1016/j.ijcard.2016.02.023. Review.

PMID:
26897076
12.

[The genetic disorders responsible for sudden cardiac death].

Harada T, Nagai R.

Nihon Rinsho. 2005 Jul;63(7):1273-83. Review. Japanese.

PMID:
16001794
13.

Congenital Long QT Syndrome: An Update and Present Perspective in Saudi Arabia.

Bhuiyan ZA, Al-Shahrani S, Al-Aama J, Wilde AA, Momenah TS.

Front Pediatr. 2013 Nov 20;1:39. doi: 10.3389/fped.2013.00039. Review.

14.

Genetic determinants of QT interval variation and sudden cardiac death.

Newton-Cheh C, Shah R.

Curr Opin Genet Dev. 2007 Jun;17(3):213-21. Review.

PMID:
17467978
15.

Genetic basis of malignant channelopathies and ventricular fibrillation in the structurally normal heart.

Hofman N, van Lochem LT, Wilde AA.

Future Cardiol. 2010 May;6(3):395-408. doi: 10.2217/fca.10.11. Review.

PMID:
20462344
16.

KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death.

Chen S, Zhang L, Bryant RM, Vincent GM, Flippin M, Lee JC, Brown E, Zimmerman F, Rozich R, Szafranski P, Oberti C, Sterba R, Marangi D, Tchou PJ, Chung MK, Wang Q.

Clin Genet. 2003 Apr;63(4):273-82.

17.

Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies.

Hsiao PY, Tien HC, Lo CP, Juang JM, Wang YH, Sung RJ.

Appl Clin Genet. 2013 Jan 18;6:1-13. doi: 10.2147/TACG.S29676.

18.

Sudden death and ion channel disease: pathophysiology and implications for management.

Bastiaenen R, Behr ER.

Heart. 2011 Sep;97(17):1365-72. doi: 10.1136/hrt.2011.223883. Review.

PMID:
21685181
19.

Cardiac channelopathies and sudden infant death syndrome.

Tfelt-Hansen J, Winkel BG, Grunnet M, Jespersen T.

Cardiology. 2011;119(1):21-33. doi: 10.1159/000329047. Review.

PMID:
21778721
20.

Molecular genetics of arrhythmias--a new paradigm.

Schulze-Bahr E, Haverkamp W, Borggrefe M, Wedekind H, Mönnig G, Mergenthaler J, Assmann G, Funke H, Breithardt G.

Z Kardiol. 2000;89 Suppl 4:IV12-22. Review.

PMID:
10810773
Items per page

Supplemental Content

Support Center